Article

Early Parkinson’s Revealed by Unlocking Longitudinal Omics at Population Scale

2026-03-14

Abstract excerpt

Many diseases begin developing years before symptoms appear 1–3 , yet biospecimens from these early stages are rarely available. We developed Chronos, a framework that uses privacy-preserving tokenization 4 to link archived plasma samples with longitudinal clinical records, enabling the modeling of molecular trajectories across time. Starting with >100 million archived, routine-donation samples from 3 million pl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3f637ae5-5714-5abb-ae10-6bddd07fad5f
DOI: 10.64898/2026.03.12.26348299

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Early Parkinson’s Revealed by Unlocking Longitudinal Omics at Population ScaleDOI 10.64898/2026.03.12.26348299Read

Mapping Parkinson’s Disease Progression through Deep Plasma Proteomics and Functional GenomicsSemantic proximity Read

Identification of Parkinson’s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal dataSemantic proximity Read

RETRACTED: A systematic genomic screen of 755 early-onset Parkinson’s patients from the 100,000 Genomes Project increases diagnostic yield and directs clinical pathwaysSemantic proximity Read

Molecular Integration in Neurological Diagnosis (MIND) Parkinson's Disease Inception Cohort Study ProtocolSemantic proximity Read

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s diseaseSemantic proximity Read

Identification of Parkinson PACE subtypes and repurposing treatments through integrative analyses of multimodal clinical progression, neuroimaging, genetic, and transcriptomic dataSemantic proximity Read

Plasma acellular transcriptome contains Parkinson’s disease signatures that can inform clinical diagnosisSemantic proximity Read

Translational Informatics for Parkinson's Disease: from Big Biomedical Data to Small Actionable Alterations.Semantic proximity Read

Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson’s diseaseSemantic proximity Read

Fox Insight at 5 years - a cohort of 54,000 participants contributing longitudinal patient-reported outcome, genetic, and microbiome data relating to Parkinson's disease.Semantic proximity Read

Changes in the cerebrospinal fluid proteome precede and stratify the course of Parkinson’s DiseaseSemantic proximity Read

Transcriptional pathobiology and multi-omics predictors for Parkinson’s diseaseSemantic proximity Read